instruction:
Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
question:
Paragraph: Citing states’ rights, jobs and the right to bear arms, congressional Republicans are reversing dozens of Obama-era rules affecting the environment, education and the energy sector. The GOP is using a largely unknown but highly effective legislative tool that allows a simple majority in the House and Senate to overturn regulations that often took years to craft. Indeed, with an overhaul of health insurance going off the rails, Republicans are left pointing to the repeal of various government regulations as their crowning legislative achievement after some 70 days at work. The GOP casts the effort as overturning eight years of excessive government regulation and boosting business. “These things will help get people back to work, and after years of sluggish growth, give a real boost to our economy,” Speaker Paul Ryan, R-Wis., said this past week. The president has signed eight resolutions revoking regulations issued during the final months of Democrat Barack Obama’s presidency. Six resolutions have cleared Congress and are awaiting the president’s signature. A couple dozen more are on deck, with last Thursday the deadline for filing more. Trump has signed measures eliminating requirements that mining and oil companies report payments made to foreign governments. The rule was designed to shine a light on how much money foreign governments received for their nation’s resources, thus reducing the prospect of corruption. He also signed another measure reversing an Obama plan to prevent coal mining debris from being dumped into nearby streams. “These actions from Congress and the president are giving hope to businesses that they haven’t had in a long time,” said Rep. Kevin Brady, R-Texas, chairman of the Ways and Means Committee. Democratic Leader Nancy Pelosi scoffed at the notion that Republicans were accomplishing anything with the regulatory repeals “because they do not meet the needs of the American people.” “They are about trickle-down. Their life is about giving more money to the high-end and to corporate interests, maybe it will trickle down, that would be good, but if it doesn’t, so be it, that’s the free market,” Pelosi said. Robert Weissman, president of Public Citizen, a consumer advocacy group, said the regulatory repeals Congress pushed through will actually damage the economy more than it helps. He said that eliminating the stream protection rule may help coal companies, but it hurts other companies that stand to gain through healthier streams and water supplies. “If you look across the terrain of the Congressional Review Act resolutions, they are repeals of public measures that help, consumers, workers and the environment in very substantial ways, but are opposed by powerful corporate interests,” Weissman said. “The Republicans driving these measures are paying back their corporate benefactors at the expense of the public.” In some cases, the regulatory repeal efforts have had nothing to do with the economy, but addressed hot-button social issues that so often dominate Washington politics. Republicans blocked a Social Security Administration rule that would have prevented tens of thousands of mentally disabled beneficiaries from being able to purchase a firearm. The rule was targeted specifically at those beneficiaries with mental disorders who have a third party manage their financial benefits, and it was opposed by the NRA and several advocacy groups for the disabled. The latest repeal effort clearing both chambers required Republicans to bring Vice President Mike Pence to the Capitol so he could cast the tie-breaking vote on the abortion issue. The scrapping of the Health and Human Services rule gave states the go-ahead to deny federal family planning money to Planned Parenthood and other abortion providers. One of the more closely contested repeals would kill an online privacy regulation. Fifteen Republicans sided with Democrats in opposing the repeal, which Pelosi said would allow internet providers to sell personal information without a user’s consent. “You should be very, very scared,” she said. The ability of Congress to void regulations with a simple majority was created in 1996 when Congress passed the Congressional Review Act. In the 20 years since, Congress was only able to use it once to repeal a regulation. Congress sent five repeal resolutions to Obama, but he vetoed each of them. Trump made clear early on that he would back the efforts of the GOP-led Congress. “I will keep working with Congress, with every agency, and most importantly with the American people until we eliminate every unnecessary, harmful and job-killing regulation that we can find,” Trump said this past week. “We have a lot more coming.” The U.S. Chamber of Commerce has encouraged the regulatory rollbacks, weighing in with lawmakers on efforts affecting internet providers, federal contractors and energy companies. Neil Bradley, a senior vice president at the Chamber, acknowledges that it’s hard to say how many jobs are created or saved through the repeal of one particular rule, but he says employers of all sizes tell the chamber government regulations are a top concern that makes it harder for them to flourish. “Any time we can roll back these regulations is another step forward to restoring the economic growth that I think is the top priority of the American people,” Bradley said. ____ On Twitter, reach Kevin Freking at https://twitter.com/APkfreking Claim: GOP Congress rolls back rules on hunting, broadband privacy.
answer:
Hunters could soon target grizzly bears from the air on Alaska’s federal lands. Internet providers may get to sell the browsing habits of their customers. States will be able to deny federal family planning money to Planned Parenthood and other abortion providers.


question:
Paragraph: The Korea Centers for Disease Control and Prevention (KCDC) said there were 47 new infections as of midnight on Sunday compared with 81 recorded a day earlier, taking the national tally to 10,284. The death toll rose by eight to 191, while another 135 people have recovered from the virus for a total of 6,598. South Korea has been bringing the epidemic under control, with about 100 or fewer new daily cases for the past month, but this was the first time the daily tally of new cases was less than 50 since 909 were reported on Feb. 29. In February, South Korea uncovered what was believed to be the biggest outbreak outside of China. But a programme of mass testing and contact tracing helped contain the virus, which has spread far more quickly in other countries. The head of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, held a 25-minute phone call with President Moon Jae-in, praising South Korea’s leadership in containing the virus, Moon’s presidential Blue House said. Moon said in the call that South Korea was “willing to actively support other countries with prevention skills and supplies as the circumstances permit”. Moon said he recently had phone calls with about 20 global leaders. Tedros proposed that Moon help support sub-Saharan African countries with virus-related supplies including test kits, the Blue House said. Despite the encouraging evidence in South Korea, officials have urged even greater vigilance, saying a large epidemic could re-emerge at any time, with smaller outbreaks appearing in churches, hospitals and nursing homes, as well as among travellers returning from abroad. “We are taking great caution against any optimistic expectations with this one-off figure,” Vice Health Minister Kim Gang-lip told a regular briefing. Click here for an interactive graphic tracking the global spread of coronavirus  On Saturday, the government extended its intensive social distancing campaign by two weeks, citing the sustained small clusters of infections. South Koreans had refrained from socialising in February when the number of cases rose exponentially but more people started going out recently as the weather became warmer and people became weary of the isolation, Kim said. The movement of people spiked about 20% over the weekend compared with the end of February, he said, citing data from the state-run statistics agency and SK Telecom, the country’s largest mobile operator. Starting on Sunday, the government toughened penalties for those who violate self-quarantine rules to up to 10 million won ($8,100) in fines or one year in prison from 3 million won  ($2,400) in fines. Authorities have reported several cases of quarantine rules being broken over the past few days. The Gunpo city government south of Seoul said on Sunday it has filed a complaint with police against a couple in their 50s and their children who broke away from isolation and went out even after testing positive for the virus. A Korean student living in the United States sparked public uproar after taking a fever remedy before flying home late last month. The student was found to have contracted the virus, putting some 20 other people who took the same flight in self quarantine. “We cannot maintain social distancing forever,” Kim said. “But it is the most effective measure to help protect others and yourself.” Claim: South Korea reports fewer than 50 new infections, earning WHO praise.
answer:
South Korea reported fewer than 50 new coronavirus cases for the first time since its peak in late February, earning the praise of the World Health Organization for combatting the spread in one of the first countries to be hard-hit by the disease.


question:
Paragraph: “It’s because my body has been suppressed for so long, it can’t fight it (cancer),” the Wisconsin resident said. Patty, who has worked at her father’s restaurant for 27 years, now struggles to handle full-time duties. “I’m trying to get disability, but I’ve been denied once already. I don’t plan on quitting working. I just need help. I need help because I can’t do a full-time job,” Patty said. In March 2017, a friend who lives in New Mexico, where medical marijuana is legal, mailed her Buddha Tears, a cannabis oil product containing cannabidiol (CBD), and THC, the psychotropic component of cannabis. After consuming a tiny amount of the oil each day — as well as smoking marijuana — Patty said she saw a massive improvement in her condition. “Unfortunately, I have to smoke everyday, because if I don’t, I will be in the bathroom all the time,” said Patty, who asked that her last name not be published because she is using an illegal substance. But these days, Patty is again struggling with the symptoms. “My connection (for CBD and marijuana) got cut off,” she said. “I’m very angry.” While Patty and others have found success treating their medical ailments with cannabis, the drug remains illegal in Wisconsin. And because of its status as a Schedule I drug — the most restrictive classification — there has been limited research in the United States about its effectiveness as medicine. The U.S. Food and Drug Administration has authorized one component of cannabis to treat serious and rare seizure disorders, as well as three drugs with synthetic cannabis substances; no other uses have been approved. ___ The nonprofit news outlet Wisconsin Watch provided this article to The Associated Press through a collaboration with Institute for Nonprofit News. ___ Although it remains illegal federally, 33 states and the District of Columbia have authorized medical use of cannabis. A bipartisan group of lawmakers has proposed legalizing it for medical use in Wisconsin, and another group of Democratic lawmakers introduced a bill in October to decriminalize possession of less than 28 grams. But Senate Majority Leader Scott Fitzgerald, R-Juneau, remains opposed. An April poll conducted by the Marquette Law School Poll showed that 83% of registered voters polled support the use of marijuana for medical purposes with a doctor’s prescription. “When issues receive more than 70% support from registered voters in Wisconsin, the Legislature needs to listen and act,” said Rep. David Bowen, D-Milwaukee. According to Dr. Angela Janis, director of psychiatry for University of Wisconsin-Madison’s University Health Services, Schedule I drugs, including marijuana, are considered to have no currently accepted medical use and a high potential for abuse, whereas for Schedule II drugs, there is less potential for abuse, and there is some therapeutic benefit. Janis is intimately familiar with this distinction. In addition to her university job, Janis is chief medical officer at LeafLine Labs, a Minnesota-based medical marijuana company. “To put this in perspective: methamphetamine is Schedule II because it’s approved for obesity. Cocaine is Schedule II because it’s approved for nasal surgery since it can constrict your blood vessels as they do surgery in your nose. So that’s the bar for what ‘medical benefit’ means,” Janis said. According to Janis, cannabis has less abuse potential than any of those substances. “Cannabis is not appropriately scheduled. And that’s one of the barriers, but not the only barrier, to research,” Janis said. Janis recommends rescheduling the drug so researchers can further study its properties. Even Smart Approaches to Marijuana (SAM), which opposes marijuana legalization, is “fully supportive” of drugs containing cannabis that have been approved by the FDA, said Colton Grace, a spokesman for the group. According to the National Institute on Drug Abuse, cannabinoids are substances within the cannabis plant that act on specific receptors in the human brain and body. They are the main active ingredients in the medical products derived from cannabis. These receptors affect many essential functions, including one’s memory, thinking, concentration and coordination. Interfering with it can have profound effects — both positive and negative. Two of the most extensively studied cannabinoids are delta-9-tetrahydrocannabinol (THC) and CBD. However, there are dozens of cannabinoids that may also have medical uses. “Many strains of the cannabis plant can have 60, 70, 80 cannabinoids in them that all interact in different ways,” Janis said. The National Institutes of Health reported spending $191 million on researching cannabinoids for medicinal use in 2017-18. Some effects are already known. For example, THC can affect the central nervous system, producing benefits such as decreased vomiting and nausea, increased appetite, reduced pain and anti-inflammatory effects. CBD also acts as an anti-inflammatory, increasing immune function, reducing pain and keeping certain cells from proliferating. Cannabinoid receptors are not in areas that control breathing, which is why there are no fatal overdoses with marijuana, Janis said. CBD actually blocks the psychotropic effects of THC, Janis said. In addition to all those cannabinoids, the cannabis sativa plant has a lot of other chemicals. For instance, terpenes, which give each strain its particular smell, such as lemon or pine, “are thought to have a lot of effects, but we just don’t know what they actually do in the body,” Janis said. In 2017, the National Academies of Sciences, Engineering and Medicine came out with one of the most comprehensive reviews of scientific research on what is known about the health effects of cannabis and cannabis-derived products. The committee considered more than 10,000 scientific abstracts. It reached nearly 100 conclusions, finding substantial evidence for just a few indications — the biggest one being pain. The report found there is substantial evidence that cannabis is an effective treatment for chronic pain in adults, specifically nerve pain, Janis said. The group also found conclusive evidence for cannabis treating chemotherapy-associated nausea and vomiting and MS-associated muscle spasms. The report also showed moderate evidence that cannabis or cannabinoids are effective for improving sleep in individuals with sleep apnea, fibromyalgia, chronic pain and multiple sclerosis. It also found limited evidence for cannabis as effective for increasing appetite and decreasing weight loss associated with HIV/AIDS, relaxing muscle tightness and pain from MS, symptoms of Tourette syndrome, anxiety and post-traumatic stress disorder (PTSD). Anecdotal evidence has also proven the effectiveness of cannabinoids for treating Rett syndrome. Norah Lowe, 10, started feeling relief from the rare neurological disorder one year ago when she began using CBD to treat her symptoms. Rett syndrome impacts nearly every part of a child’s life, including the ability to speak, walk, eat and breathe. A distinct feature of the condition is repetitive, almost constant hand movements. At a news conference arranged by state Rep. Melissa Sargent, D-Madison, to introduce her latest bill to legalize medical and recreational marijuana, Norah’s father, Josh Lowe, said he is frustrated that state law prohibits her from trying medical marijuana, which has helped others with her condition. Norah, who uses a wheelchair, has experienced “increased flexibility, decreased pain and muscle cramping, increased communication, cognitive ability, reduction in seizures, better mood control, and the list goes on and on,” Lowe said. A 2017 study published in the Cochrane Database of Systematic Reviews analyzed several studies, concluding that cannabis-based medicines were better than placebos for pain relief — and that these medications also improved sleep and psychological distress — it concluded that any potential benefits might be outweighed by their potential harms. According to the Marijuana Policy Project, the most common conditions accepted by states that allow medicinal cannabis relate to the relief of the symptoms of cancer, glaucoma, HIV/AIDS and MS. Some other common indicators include Alzheimer’s disease, inflammatory bowel disease, Crohn’s, Parkinson’s disease and PTSD, according to the group, which advocates for marijuana legalization. Additionally, the University of Michigan published a study in the February issue of Health Affairs to understand the reasons why people are using cannabis for medical purposes, and whether those purposes are evidence-based. The authors found that 85.5% t of uses of medical cannabis were for conditions for which there was substantial or conclusive evidence of their therapeutic effectiveness. Even more, they found that chronic pain is currently the most common qualifying condition reported by medical cannabis patients, used by 64.9% of such patients in 2016. “That’s a good sign,” Janis said. “Even though a physician can write it (a cannabis prescription) for a variety of things, it seems to be being used for what it’s intended for.” Since cannabis is a Schedule I drug, it is “very difficult to study at any institutional level” because, in order to do so, researchers need sign-offs from the U.S. Drug Enforcement Agency, which has “historically been unwilling to provide them,” said David Abernathy, vice president of data and government affairs for the Arcview Group, a firm that advises investors in the cannabis industry. Because of this, “Things like double-blind placebo-controlled clinical trials weren’t happening in the U.S.,” Abernathy said. But there has been a lot of research in the past decade in other countries including Israel, Canada, China and Italy, and “now we’re starting to see more research in the U.S.,” he said. The 2017 National Academies review of cannabis research agreed that the drug’s status as a Schedule I substance made it hard to study. “Researchers also often find it difficult to gain access to the quantity, quality, and type of cannabis product necessary to address specific research questions,” the review found. Patty, the Crohn’s patient, believes that her cannabis treatment not only alleviated her Crohn’s symptoms, but she credits it with keeping her aggressive skin cancer at bay. According to a 2018 article published in Biochemical Pharmacology, studies have shown the potential of cannabinoids to reduce of skin cancer progression. However, there is a significant lack of clinical studies promising enough to make any conclusive statements at this time. “I haven’t had the cannabis oil since March of 2018, and once I couldn’t get it anymore, I mean I just finished my 12th surgery (for cancer),” Patty said. “So, you tell me, what do you think?” Claim: Wisconsin residents using medical cannabis amid restrictions.
answer:

After four decades of using strong prescription drugs to treat Crohn’s disease, a chronic digestive disorder, Patty developed an aggressive form of skin cancer.